Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia

Cefoperazone/sulbactam (CPZ/SUL) is a β-lactam and β-lactamase inhibitor combination therapy for the treatment of respiratory tract infections. Using data from a prospective, multiple-center, open-label clinical trial in 54 patients with hospital-acquired pneumonia or ventilator-associated pneumonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yingjie, Zhang, Jing, Chen, Yuancheng, Wu, Jufang, Guo, Beining, Wu, Xiaojie, Zhang, Yingyuan, Wang, Minggui, Ya, Ru, Huang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138011/
https://www.ncbi.nlm.nih.gov/pubmed/35625347
http://dx.doi.org/10.3390/antibiotics11050703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138011/
https://www.ncbi.nlm.nih.gov/pubmed/35625347
http://dx.doi.org/10.3390/antibiotics11050703

Ejemplares similares